Smith Thomas B

Smith Thomas B is listed in filings as EVP and Chief Medical Officer at Collegium Pharmaceutical, Inc.. This profile follows SEC Form 4 activity through Feb 12, 2026, including sale activity. Recent filings connect the profile to Collegium Pharmaceutical, Inc. (COLL). The current snapshot covers public activity from Sep 17, 2024 to Feb 12, 2026. Reported amounts are shown as $539.4K to $671.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.